Clarifo Logo
Clarifo Research

Research companies. Publish your view. See if it holds.

Analysts, advisers and investors publish company analysis on Clarifo, built on reported figures with every number linked to the filing it came from. Read it, subscribe to the authors you trust, or publish your own: for your clients, your followers or just yourself.

Start researchingBrowse research
From the Clarifo research desk

Clarifo’s public analyses

Our own company and earnings analyses, published in the same library format every author gets.

Clarifo Research@clarifo
  1. JP Morgan Chase & Co · Q3 2026. Revenue rose 8.1% to $50.17B and diluted EPS 9.9% to $5.57, while net income grew a slower 6.3%.

    JPMorgan Q3 2026: Buybacks slowed to July only as new $50 billion program began

    JPMorgan Q3 2026 buybacks slowed sharply to July only, while revenue and net income rose year over year.

  2. BioMarin Pharmaceutical Inc · Q3 2026. Revenue rose 32.0% to $1.02B, but the net loss widened from $30.74M to $122.83M.

    BioMarin Q3 2026: Amicus lifts revenue past $1B but financing costs widen the loss

    BioMarin Q3 2026 revenue rose 32% above $1B on Amicus products, but higher debt, amortization and IPR&D widened losses.

  3. Atlantic Union Bankshares Corp · Q3 2026. Net income rose 48.3% to $136.63M in fiscal Q3 2026, yet Consumer Banking pre-tax income fell $7.2M on a deposit funding credit.

    Atlantic Union Q3 2026: profit up 48% as merger costs lapse, margin slipped from the prior quarter

    Atlantic Union Q3 2026 profit rose 48% as merger costs faded, but net interest margin slipped and credit trends were mixed.

All Clarifo research
Latest

New research

Publicly listed analyses from every author, newest first. Only research that has passed moderation appears here.

How it works

From question to published analysis

The research, the document and the audience live in one place, so the numbers your readers see are the numbers you checked.

  1. 01

    Research

    Work from the filings themselves, not from a dataset someone else assembled.

    • Ask questions across annual reports, interim reports and SEC filings
    • Compare companies and periods in one table
    • Every figure links to the page of the report it came from

  2. 02

    Publish

    Turn the work into a document and decide who reads it.

    • Public in your research library, for anyone and for search engines
    • Only people with the link, for clients and colleagues
    • Private, as your own record; or scheduled for a set time

  3. 03

    Follow

    Readers come back when there is something new, without you sending a thing.

    • Readers subscribe to you and hear about each new publication
    • You follow companies and get a brief when they report
    • Read counts show which analyses people actually open
Track your view

See your analyses against what happened next

A view is only useful if you can check it later. Clarifo keeps your analyses, theses and notes next to the companies and the prices they were about.

  • Your analyses on the price chart

    Turn on “Show my analyses” in a portfolio and every analysis, thesis and note appears on the chart at the date you wrote it.

  • A note on every holding

    Write down the thesis and what to watch for each portfolio company. The workspace chat reads it when you ask about the portfolio.

  • Positions and total return

    Record positions and follow the portfolio’s total return and price charts over time.

Share price1Initial thesis2Q2 review3Q3 update
Illustration: a price line with three analyses marked at the dates they were written.
Who it is for

Publish for clients, for followers, or for yourself

  • Independent analysts and writers

    Build a public library under your own name, grow subscribers and let readers check every figure you cite.

  • Advisers and wealth managers

    Share analysis with clients through a private link and keep the reasoning behind each recommendation on record.

  • Private investors

    Keep your research private, put your theses on the price chart and see which calls held up.

Moderated, sourced, and clearly the author’s view

Every public publication goes through an automated content review, and flagged documents go to a human moderator before they reach the feed or subscribers. Research is the author’s own opinion, not investment advice. Content policy

Start your research library.

Try Clarifo free for 7 days. Research from the filings, publish when you are ready.

Start a free trial